The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of “Stealthy” Nanomaterials
Open accessAbstract
In the last decades, the staggering progress in nanotechnology brought around a wide and heterogeneous range of nanoparticle-based platforms for the diagnosis and treatment of many diseases. Most of these systems are designed to be administered intravenously. This administration route allows the nanoparticles (NPs) to widely distribute in the body and reach deep organs without invasive techniques. When these nanovectors encounter the biological environment of systemic circulation, a dynamic interplay occurs between the circulating proteins and the NPs, themselves. The set of proteins that bind to the NP surface is referred to as the protein corona (PC). PC has a critical role in making the particles easily recognized by the innate immune system, causing their quick clearance by phagocytic cells located in organs such as the lungs, liver, and spleen. For the same reason, PC defines the immunogenicity of NPs by priming the immune response to them and, ultimately, their immunological toxicity. Furthermore, the protein corona can cause the physical destabilization and agglomeration of particles. These problems induced to consider the PC only as a biological barrier to overcome in order to achieve efficient NP-based targeting. This review will discuss the latest advances in the characterization of PC, development of stealthy NP formulations, as well as the manipulation and employment of PC as an alternative resource for prolonging NP half-life, as well as its use in diagnostic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“The use of different moieties has been extensively discussed in other works and goes beyond the scope of the present paper (Blanco et al., 2015; Parodi et al., 2015).”
BackgroundDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces
Vroman, L., Adams, A., Fischer, G., & Munoz, P. (1980) · Blood · doi:10.1182/blood.v55.1.156.156 · Cited by 781
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Xia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Albumin and its application in drug delivery
Sleep, D. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 464
Biomimetic proteolipid vesicles for targeting inflamed tissues
Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., Yazdi, I. K., Zhao, P., De Rosa, E., Sherman, M. B., et al. (2016) · Nature Materials · doi:10.1038/nmat4644 · Cited by 451
Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh, J. Y., Kim, H. S., Palanikumar, L., Go, E. M., Jana, B., Park, S. A., Kim, H. Y., Kim, K., Seo, J. K., Kwak, S. K., et al. (2018) · Nature communications · doi:10.1038/s41467-018-06979-4 · Cited by 409 · cited 1×
“Another recent work by Oh et al. (2018) further expands and improves this model.”
BackgroundIn vivo formation of protein corona on gold nanoparticles. The effect of their size and shape
García-Álvarez, R., Hadjidemetriou, M., Sánchez-Iglesias, A., Liz-Marzán, L. M., & Kostarelos, K. (2018) · Nanoscale · doi:10.1039/c7nr08322j · Cited by 373
Hadjidemetriou, M., Al-Ahmady, Z., Mazza, M., Collins, R. F., Dawson, K., & Kostarelos, K. (2015) · ACS Nano · doi:10.1021/acsnano.5b03300 · Cited by 358
Saha, K., Rahimi, M., Yazdani, M., Kim, S. T., Moyano, D. F., Hou, S., Das, R., Mout, R., Rezaee, F., Mahmoudi, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00053 · Cited by 355
Brain-targeted drug delivery by manipulating protein corona functions
Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334
Personalized protein corona on nanoparticles and its clinical implications
Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Biomaterials Science · doi:10.1039/c6bm00921b · Cited by 308
Zwitteration As an Alternative to PEGylation
Estephan, Z. G., Schlenoff, P. S., & Schlenoff, J. B. (2011) · Langmuir · doi:10.1021/la200227b · Cited by 267
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
Parodi, A., Molinaro, R., Sushnitha, M., Evangelopoulos, M., Martinez, J. O., Arrighetti, N., Corbo, C., & Tasciotti, E. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.020 · Cited by 266
Hadjidemetriou, M., Al-Ahmady, Z., & Kostarelos, K. (2016) · Nanoscale · doi:10.1039/c5nr09158f · Cited by 214
Zhou, H., Fan, Z., Li, P. Y., Deng, J., Arhontoulis, D. C., Li, C. Y., Bowne, W. B., & Cheng, H. (2018) · ACS Nano · doi:10.1021/acsnano.8b04947 · Cited by 212
Evolution of Nanoparticle Protein Corona across the Blood–Brain Barrier
Cox, A., Andreozzi, P., Dal Magro, R., Fiordaliso, F., Corbelli, A., Talamini, L., Chinello, C., Raimondo, F., Magni, F., Tringali, M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03500 · Cited by 208
Almalik, A., Benabdelkamel, H., Masood, A., Alanazi, I. O., Alradwan, I., Majrashi, M. A., Alfadda, A. A., Alghamdi, W. M., Alrabiah, H., Tirelli, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10836-7 · Cited by 195
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof‐of‐Concept Clinical Study
Hadjidemetriou, M., McAdam, S., Garner, G., Thackeray, C., Knight, D., Smith, D., Al‐Ahmady, Z., Mazza, M., Rogan, J., Clamp, A., et al. (2019) · Advanced Materials · doi:10.1002/adma.201803335 · Cited by 171
Juang, V., Chang, C., Wang, C., Wang, H., & Lo, Y. (2019) · Small · doi:10.1002/smll.201903296 · Cited by 164
The biomolecular corona of nanoparticles in circulating biological media
Pozzi, D., Caracciolo, G., Digiacomo, L., Colapicchioni, V., Palchetti, S., Capriotti, A. L., Cavaliere, C., Zenezini Chiozzi, R., Puglisi, A., & Laganà, A. (2015) · Nanoscale · doi:10.1039/c5nr03701h · Cited by 163
Pasut, G., Paolino, D., Celia, C., Mero, A., Joseph, A. S., Wolfram, J., Cosco, D., Schiavon, O., Shen, H., & Fresta, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.008 · Cited by 158
Techniques for the experimental investigation of the protein corona
Carrillo-Carrion, C., Carril, M., & Parak, W. J. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.02.009 · Cited by 158
Chen, D., Ganesh, S., Wang, W., & Amiji, M. M. (2019) · Nanoscale · doi:10.1039/c8nr09855g · Cited by 158
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Takeuchi, T., Kitayama, Y., Sasao, R., Yamada, T., Toh, K., Matsumoto, Y., & Kataoka, K. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201700647 · Cited by 150
Gold Nanoparticle-Enabled Blood Test for Early Stage Cancer Detection and Risk Assessment
Zheng, T., Pierre-Pierre, N., Yan, X., Huo, Q., Almodovar, A. J. O., Valerio, F., Rivera, I., Griffith, E. C., Decker, D., Chen, S., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00371 · Cited by 142
Ding, H., Lv, Y., Ni, D., Wang, J., Tian, Z., Wei, W., & Ma, G. (2015) · Nanoscale · doi:10.1039/c5nr02470f · Cited by 135
Grenier, P., Viana, I. M. D. O., Lima, E. M., & Bertrand, N. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.022 · Cited by 133
Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
Caracciolo, G., Palchetti, S., Colapicchioni, V., Digiacomo, L., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02158 · Cited by 131
Coating nanoparticles with tunable surfactants facilitates control over the protein corona
Müller, J., Bauer, K. N., Prozeller, D., Simon, J., Mailänder, V., Wurm, F. R., Winzen, S., & Landfester, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.015 · Cited by 128
Dai, Q., Yan, Y., Ang, C., Kempe, K., Kamphuis, M. M. J., Dodds, S. J., & Caruso, F. (2015) · ACS Nano · doi:10.1021/nn506929e · Cited by 121
Rao, L., Xu, J., Cai, B., Liu, H., Li, M., Jia, Y., Xiao, L., Guo, S., Liu, W., & Zhao, X. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/8/085106 · Cited by 121
Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles
Partikel, K., Korte, R., Mulac, D., Humpf, H., & Langer, K. (2019) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.10.101 · Cited by 121
Martinez, J. O., Molinaro, R., Hartman, K. A., Boada, C., Sukhovershin, R. A., Rosa, E. D., Kuri, D., Zhang, S., Evangelopoulos, M., Carter, A. M., et al. (2018) · Theranostics · doi:10.7150/thno.22078 · Cited by 116
Ye, S., Wang, F., Fan, Z., Zhu, Q., Tian, H., Zhang, Y., Jiang, B., Hou, Z., Li, Y., & Su, G. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00897 · Cited by 113
Zhong, L., Xu, L., Liu, Y., Li, Q., Zhao, D., Li, Z., Zhang, H., Zhang, H., Kan, Q., Wang, Y., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.006 · Cited by 104
Varnamkhasti, B. S., Hosseinzadeh, H., Azhdarzadeh, M., Vafaei, S. Y., Esfandyari‐Manesh, M., Mirzaie, Z. H., Amini, M., Ostad, S. N., Atyabi, F., & Dinarvand, R. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.060 · Cited by 102
Enabling Cytoplasmic Delivery and Organelle Targeting by Surface Modification of Nanocarriers
Parodi, A., Corbo, C., Cevenini, A., Molinaro, R., Palomba, R., Pandolfi, L., Agostini, M., Salvatore, F., & Tasciotti, E. (2015) · Nanomedicine · doi:10.2217/nnm.15.39 · Cited by 102
Self-citationWeber, C., Voigt, M., Simon, J., Danner, A., Frey, H., Mailänder, V., Helm, M., Morsbach, S., & Landfester, K. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00539 · Cited by 98
A protein corona-enabled blood test for early cancer detection
Caputo, D. D., Papi, M., Coppola, R., Palchetti, S., Digiacomo, L., Caracciolo, G., & Pozzi, D. (2016) · Nanoscale · doi:10.1039/c6nr05609a · Cited by 96
Su, G., Jiang, H., Xu, B., Yu, Y., & Chen, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00612 · Cited by 96
Ye, L., Zhang, Y., Yang, B., Zhou, X., Li, J., Qin, Z., Dong, D., Cui, Y., & Yao, F. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b10811 · Cited by 94
Weber, C., Simon, J., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.057 · Cited by 94
Abstiens, K., Figueroa, S. M., Gregoritza, M., & Göpferich, A. M. (2018) · Soft Matter · doi:10.1039/c8sm02189a · Cited by 88
Corbo, C., Cromer, W. E., Molinaro, R., Furman, N. E. T., Hartman, K. A., Rosa, E. D., Boada, C., Wang, X., Zawieja, D. C., Agostini, M., et al. (2017) · Nanoscale · doi:10.1039/c7nr04734g · Cited by 82
Self-citationThe concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM)
Westmeier, D., Stauber, R. H., & Docter, D. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.008 · Cited by 79
Beyond the protein corona—Lipids matter for biological response of nanocarriers
Müller, J., Prozeller, D., Ghazaryan, A., Kokkinopoulou, M., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.036 · Cited by 79
Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation
Xu, F., Reiser, M. L., Yu, X., Gummuluru, S., Wetzler, L. M., & Reinhard, B. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b06501 · Cited by 78
Ho, Y. T., Azman, N. ‘., Loh, F. W. Y., Ong, G. K. T., Engudar, G., Kriz, S. A., & Kah, J. C. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00743 · Cited by 78
Analytical Methods for Characterizing the Nanoparticle–Protein Corona
Capriotti, A. L., Caracciolo, G., Cavaliere, C., Colapicchioni, V., Piovesana, S., Pozzi, D., & Laganà, A. (2014) · Chromatographia · doi:10.1007/s10337-014-2677-x · Cited by 77
Gorshkov, V., Bubis, J. A., Solovyeva, E. M., Gorshkov, M. V., & Kjeldsen, F. (2019) · Environmental Science Nano · doi:10.1039/c8en01054d · Cited by 75
Canovi, M., Lucchetti, J., Stravalaci, M., Re, F., Moscatelli, D., Bigini, P., Salmona, M., & Gobbi, M. (2012) · Sensors · doi:10.3390/s121216420 · Cited by 71
Jenkins, S. I., Weinberg, D., al-Shakli, A. F., Fernandes, A. R., Yiu, H. H. P., Telling, N. D., Roach, P., & Chari, D. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.013 · Cited by 70
Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting
Cui, J., Björnmalm, M., Ju, Y., & Caruso, F. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02117 · Cited by 70
Probing fibronectin conformation on a protein corona layer around nanoparticles
Raoufi, M., Hajipour, M. J., Shahri, S. M. K., Schoen, I., Linn, U., & Mahmoudi, M. (2017) · Nanoscale · doi:10.1039/c7nr06970g · Cited by 68
Oral delivery of nanoparticles - let’s not forget about the protein corona
Berardi, A., & Bombelli, F. B. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1610384 · Cited by 67
Molinaro, R., Pastò, A., Corbo, C., Taraballi, F., Giordano, F., Martinez, J. O., Zhao, P., Wang, X., Zinger, A., Boada, C., et al. (2019) · Nanoscale · doi:10.1039/c9nr04253a · Cited by 61
Protein corona in drug delivery for multimodal cancer therapy in vivo
Yeo, E. L. L., Thong, P. S. P., Soo, K. C., & Kah, J. C. Y. (2017) · Nanoscale · doi:10.1039/c7nr08509e · Cited by 58
A comparison of the human and mouse protein corona profiles of functionalized SiO 2 nanocarriers
Solorio-Rodríguez, A., Escamilla‐Rivera, V., Uribe-Ramírez, M., Chagolla, A., Winkler, R., García-Cuellar, C. M., & Vizcaya‐Ruíz, A. D. (2017) · Nanoscale · doi:10.1039/c7nr04685e · Cited by 57
Vroman, L., & Adams, A. L. (1964) · Nature · doi:10.1038/204701b0 · Cited by 56
Coty, J.-B., Oliveira, E. E., & Vauthier, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.048 · Cited by 54
Zhang, T., Zhu, G.-Y., Lu, B., Zhang, C., & Peng, Q. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0238 · Cited by 48
Chen, J., Yang, X., Huang, L., Lai, H., Gan, C., & Luo, X. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1477856 · Cited by 48
Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment
Bonvin, D., Aschauer, U., Alexander, D. T. L., Chiappe, D., Moniatte, M., Hofmann, H., & Ebersold, M. M. (2017) · Small · doi:10.1002/smll.201700409 · Cited by 46
Li, Z., Li, D., Li, Q., Luo, C., Li, J., Kou, L., Zhang, D., Zhang, H., Zhao, S., Kan, Q., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm00692j · Cited by 45
de Oliveira, J. F. A., Scheffer, F. R., Landis, R. F., Neto, É. T., Rotello, V. M., & Cardoso, M. B. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12351 · Cited by 44
Gulati, N. M., Pitek, A. S., Czapar, A. E., Stewart, P. L., & Steinmetz, N. F. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03106h · Cited by 43
Liposome protein corona characterization as a new approach in nanomedicine
Capriotti, A. L., Cavaliere, C., & Piovesana, S. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01656-x · Cited by 37
Li, D., Wang, F., Di, H., Liu, X., Zhang, P., Zhou, W. J., & Liu, D. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b01325 · Cited by 32
Stealth Iron Oxide Nanoparticles for Organotropic Drug Targeting
Magro, M., Baratella, D., Bonaiuto, E., Roger, J. D. A., Chemello, G., Pasquaroli, S., Mancini, L., Olivotto, I., Zoppellaro, G., Ugolotti, J., et al. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.8b01750 · Cited by 31
Viard, M., Reichard, H., Shapiro, B. A., Durrani, F. A., Marko, A. J., Watson, R., Pandey, R. K., & Puri, A. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.07.006 · Cited by 27
Viral nanoparticles can elude protein barriers: exploiting rather than imitating nature
Berardi, A., Bombelli, F. B., Thuenemann, E. C., & Lomonossoff, G. P. (2019) · Nanoscale · doi:10.1039/c8nr09067j · Cited by 24
Zhang, S., Tang, C., & Yin, C. (2013) · Drug Delivery · doi:10.3109/10717544.2013.854849 · Cited by 23
Trends towards Biomimicry in Theranostics
Evangelopoulos, M., Parodi, A., Martinez, J. O., & Tasciotti, E. (2018) · Nanomaterials · doi:10.3390/nano8090637 · Cited by 21
Naidu, P. S. R., Nörret, M., Smith, N. M., Dunlop, S. A., Taylor, N. L., Fitzgerald, M., & Iyer, K. S. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b02568 · Cited by 19
How Low Can You Go? Low Densities of Poly(ethylene glycol) Surfactants Attract Stealth Proteins
Seneca, S., Simon, J., Weber, C., Ghazaryan, A., Ethirajan, A., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800075 · Cited by 18
Multiscale Modelling of Bionano Interface
Silva, H. L., Brandt, E. G., Mirzoev, A., Zhurkin, D., Lyubartsev, A. P., & Lobaskin, V. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47754-1_7 · Cited by 15
Pederzoli, F., Tosi, G., Genovese, F., Belletti, D., Vandelli, M. A., Ballestrazzi, A., Forni, F., & Ruozi, B. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0250 · Cited by 15
Cited by
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Lipid-based nanoparticle technologies for liver targeting
Böttger, R., Pauli, G., Chao, P.-H., AL Fayez, N., Hohenwarter, L., & Li, S.-D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.017 · Cited by 264
Janjua, T. I., Cao, Y., Kleitz, F., Linden, M., Yu, C., & Popat, A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115115 · Cited by 259
The effects of protein corona on in vivo fate of nanocarriers
Xiao, Q., Zoulikha, M., Qiu, M., Teng, C., Lin, C., Li, X., Sallam, M. A., Xu, Q., & He, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114356 · Cited by 255
Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
Vlatkovic, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050530 · Cited by 112
Metadata
- Authors
- Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-03
- Volume
- 8
- Pages
- 166-166
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W3014236874
- Cited by
- 390
- References
- 87
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.